Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas W Morrell

Showing results (201-210 of 278) with videos related to

Pageof 28
Sort By:
Respiratory Research|April 27, 2026
Tracking the evolution of biomarker efficacy in SARS-CoV-2: a global meta-analyses seriesMe Rahman Shuvo, Max Schwiening, Nikos Avramidis, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 7, 2023
Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH-Results from a prospective discovery and validation biomarker studyCharaka M Hadinnapola, Mark Southwood, Jules Hernández-Sánchez, et al.
American Journal of Respiratory and Critical Care Medicine|February 4, 2014
An official American Thoracic Society Statement: pulmonary hypertension phenotypesRaed A Dweik, Sharon Rounds, Serpil C Erzurum, et al.
Molecular Genetics & Genomic Medicine|April 9, 2021
Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an "HHT-like" syndrome in childrenJoshua Hodgson, Lidia Ruiz-Llorente, Jamie McDonald, et al.
The Journal of Pathology|July 2, 2019
Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertensionMaria Catalina Gomez-Puerto, Iris van Zuijen, Christopher Jz Huang, et al.
Angiogenesis|November 12, 2025
BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivityBenjamin J Dunmore, Stephen Moore, Rowena J Jones, et al.
Thorax|December 17, 2018
Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertensionBenjamin E Garfield, Alexi Crosby, Dongmin Shao, et al.
Frontiers in Physiology|July 29, 2017
Bone Morphogenetic Protein 9 Protects against Neonatal Hyperoxia-Induced Impairment of Alveolarization and Pulmonary InflammationXueyu Chen, Mar Orriols, Frans J Walther, et al.
Nature Communications|January 14, 2017
TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signallingLiam A Hurst, Benjamin J Dunmore, Lu Long, et al.
The Journal of Experimental Medicine|October 17, 2012
Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertensionAbdul G Hameed, Nadine D Arnold, Janet Chamberlain, et al.
Pageof 28

Showing results (201-210 of 278) with videos related to

Sort By:
Pageof 28
Respiratory Research|April 27, 2026
Tracking the evolution of biomarker efficacy in SARS-CoV-2: a global meta-analyses seriesMe Rahman Shuvo, Max Schwiening, Nikos Avramidis, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 7, 2023
Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH-Results from a prospective discovery and validation biomarker studyCharaka M Hadinnapola, Mark Southwood, Jules Hernández-Sánchez, et al.
American Journal of Respiratory and Critical Care Medicine|February 4, 2014
An official American Thoracic Society Statement: pulmonary hypertension phenotypesRaed A Dweik, Sharon Rounds, Serpil C Erzurum, et al.
Molecular Genetics & Genomic Medicine|April 9, 2021
Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an "HHT-like" syndrome in childrenJoshua Hodgson, Lidia Ruiz-Llorente, Jamie McDonald, et al.
The Journal of Pathology|July 2, 2019
Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertensionMaria Catalina Gomez-Puerto, Iris van Zuijen, Christopher Jz Huang, et al.
Angiogenesis|November 12, 2025
BMP9 knockout impairs pulmonary vessel muscularisation and confers aberrant tamoxifen sensitivityBenjamin J Dunmore, Stephen Moore, Rowena J Jones, et al.
Thorax|December 17, 2018
Growth/differentiation factor 15 causes TGFβ-activated kinase 1-dependent muscle atrophy in pulmonary arterial hypertensionBenjamin E Garfield, Alexi Crosby, Dongmin Shao, et al.
Frontiers in Physiology|July 29, 2017
Bone Morphogenetic Protein 9 Protects against Neonatal Hyperoxia-Induced Impairment of Alveolarization and Pulmonary InflammationXueyu Chen, Mar Orriols, Frans J Walther, et al.
Nature Communications|January 14, 2017
TNFα drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signallingLiam A Hurst, Benjamin J Dunmore, Lu Long, et al.
The Journal of Experimental Medicine|October 17, 2012
Inhibition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertensionAbdul G Hameed, Nadine D Arnold, Janet Chamberlain, et al.
Pageof 28